Janney Montgomery Scott’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.1M | Buy |
+72,758
| New | +$20.1M | 0.03% | 521 |
|
|
2026
Q1 | – | Sell |
-63,826
| Closed | -$17.4M | – | 2796 |
|
|
2025
Q4 | $17.4M | Buy |
63,826
+6,554
| +11% | +$1.78M | 0.04% | 412 |
|
|
2025
Q3 | $15.5M | Sell |
57,272
-192
| -0.3% | -$52.2K | 0.04% | 452 |
|
|
2025
Q2 | $15.8M | Buy |
57,464
+654
| +1% | +$178K | 0.04% | 399 |
|
|
2025
Q1 | $15.1M | Buy |
56,810
+1,052
| +2% | +$259K | 0.04% | 408 |
|
|
2024
Q4 | $12.9M | Buy |
55,758
+7,285
| +15% | +$1.68M | 0.04% | 459 |
|
|
2024
Q3 | $10.7M | Sell |
48,473
-663
| -1% | -$137K | 0.03% | 514 |
|
|
2024
Q2 | $9.66M | Sell |
49,136
-3,031
| -6% | -$626K | 0.03% | 520 |
|
|
2024
Q1 | $11.2M | Buy |
52,167
+12,653
| +32% | +$2.66M | 0.03% | 494 |
|
|
2023
Q4 | $8.32M | Sell |
39,514
-143
| -0.4% | -$30.5K | 0.03% | 556 |
|
|
2023
Q3 | $7.94M | Buy |
39,657
+4,302
| +12% | +$855K | 0.03% | 514 |
|
|
2023
Q2 | $6.55M | Sell |
35,355
-650
| -2% | -$120K | 0.02% | 605 |
|
|
2023
Q1 | $6.9M | Buy |
36,005
+6,699
| +23% | +$1.21M | 0.03% | 529 |
|
|
2022
Q4 | $4.93M | Sell |
29,306
-1,579
| -5% | -$274K | 0.02% | 683 |
|
|
2022
Q3 | $5.47M | Buy |
30,885
+1,667
| +6% | +$329K | 0.02% | 584 |
|
|
2022
Q2 | $6.01M | Sell |
29,218
-4,220
| -13% | -$895K | 0.03% | 535 |
|
|
2022
Q1 | $7.95M | Buy |
33,438
+1,547
| +5% | +$363K | 0.03% | 445 |
|
|
2021
Q4 | $7.29M | Buy |
31,891
+9,146
| +40% | +$2.01M | 0.03% | 502 |
|
|
2021
Q3 | $4.4M | Buy |
22,745
+926
| +4% | +$188K | 0.02% | 642 |
|
|
2021
Q2 | $4.64M | Buy |
21,819
+168
| +0.8% | +$35.5K | 0.02% | 609 |
|
|
2021
Q1 | $4.42M | Buy |
21,651
+1,145
| +6% | +$226K | 0.02% | 601 |
|
|
2020
Q4 | $3.73M | Sell |
20,506
-980
| -5% | -$167K | 0.02% | 624 |
|
|
2020
Q3 | $3.6M | Buy |
21,486
+118
| +0.6% | +$19.9K | 0.02% | 589 |
|
|
2020
Q2 | $3.47M | Buy |
21,368
+438
| +2% | +$78.5K | 0.02% | 566 |
|
|
2020
Q1 | $3.62M | Sell |
20,930
-6,978
| -25% | -$1.39M | 0.03% | 489 |
|
|
2019
Q4 | $5.6M | Buy |
27,908
+5,760
| +26% | +$1.18M | 0.04% | 424 |
|
|
2019
Q3 | $4.68M | Sell |
22,148
-2,046
| -8% | -$427K | 0.03% | 458 |
|
|
2019
Q2 | $4.7M | Sell |
24,194
-3,254
| -12% | -$600K | 0.04% | 444 |
|
|
2019
Q1 | $4.52M | Buy |
27,448
+3,591
| +15% | +$635K | 0.04% | 429 |
|
|
2018
Q4 | $4.49M | Buy |
23,857
+698
| +3% | +$129K | 0.04% | 391 |
|
|
2018
Q3 | $3.94M | Sell |
23,159
-332
| -1% | -$55.9K | 0.03% | 479 |
|
|
2018
Q2 | $3.85M | Buy |
23,491
+1,166
| +5% | +$190K | 0.04% | 447 |
|
|
2018
Q1 | $3.61M | Buy |
22,325
+8,401
| +60% | +$1.34M | 0.04% | 459 |
|
|
2017
Q4 | $2.03M | Sell |
13,924
-600
| -4% | -$85.5K | 0.02% | 640 |
|
|
2017
Q3 | $1.97M | Sell |
14,524
-1,126
| -7% | -$142K | 0.02% | 622 |
|
|
2017
Q2 | $1.96M | Buy |
15,650
+10,600
| +210% | +$1.27M | 0.02% | 580 |
|
|
2017
Q1 | $600K | Buy |
5,050
+3,170
| +169% | +$381K | 0.01% | 1083 |
|
|
2016
Q4 | $217K | Sell |
1,880
-251
| -12% | -$27.9K | ﹤0.01% | 1502 |
|
|
2016
Q3 | $223K | Buy |
+2,131
| New | +$222K | ﹤0.01% | 1336 |
|
Other funds holding CME
Janney Montgomery Scott's CME Position: Q2 2026 in Review
Janney Montgomery Scott opened a new position in CME Group (CME) in Q2 2026: 72,758 shares worth $16.1M. The stake represents 0.03% of the portfolio and ranks #521 among its holdings. This is a return to the name: Janney Montgomery Scott previously reported a position in CME as recently as Q4 2025.
Janney Montgomery Scott first reported a position in CME in Q3 2016 and has held it in 39 quarters since. The position peaked at $17.4M in Q4 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Janney Montgomery Scott held 72,758 shares of CME Group worth $16.1M as of Q2 2026.
- CME Group was a new Janney Montgomery Scott position in Q2 2026.
- CME Group made up 0.03% of Janney Montgomery Scott's portfolio in Q2 2026, its #521 holding.
- Janney Montgomery Scott first reported a position in CME Group in Q3 2016 and has held it in 39 quarters since.
- Janney Montgomery Scott's CME Group position peaked at $17.4M in Q4 2025.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.